Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-24

Clinical Trial Update: Prophylactic Pregabalin Treatment Following Spinal Cord Injury [NA]

View source ↗

Summary

A clinical trial update describes a study evaluating prophylactic pregabalin after spinal cord injury, sponsored by Loewenstein Hospital, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Loewenstein Hospital | Conditions: Spinal Cord Injuries, Spinal Cord Diseases | NA | Status: RECRUITING